{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T21:06:27Z","timestamp":1762376787628,"version":"3.44.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["14-04-00012","18-015-00009"],"award-info":[{"award-number":["14-04-00012","18-015-00009"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jss.2020.07.022","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T11:25:11Z","timestamp":1598009111000},"page":"178-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1894-5761","authenticated-orcid":false,"given":"Oleg","family":"Pisarenko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7904-3817","authenticated-orcid":false,"given":"Irina","family":"Studneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2020.07.022_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40140-013-0024-7","article-title":"Perioperative implications of vascular endothelial dysfunction: current understanding of this critical sensor-effector organ","volume":"3","author":"Riedel","year":"2013","journal-title":"Curr Anesthesiol Rep"},{"key":"10.1016\/j.jss.2020.07.022_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8364848","article-title":"The dual role of inducible nitric oxide synthase in myocardial ischemia\/reperfusion injury: friend or foe?","author":"Yu","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jss.2020.07.022_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/bs.apha.2017.08.001","article-title":"Mechanisms of I\/R-induced endothelium-dependent vasodilator dysfunction","volume":"81","author":"Korthuis","year":"2018","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mayocpiqo.2018.12.006","article-title":"Rethinking endothelial dysfunction as a crucial target in fighting heart failure","volume":"3","author":"Premer","year":"2019","journal-title":"Mayo Clin Proc Inn Qual Out"},{"key":"10.1016\/j.jss.2020.07.022_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/152308601300185179","article-title":"Mechanisms of the antioxidant effects of nitric oxide","volume":"3","author":"Wink","year":"2001","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jss.2020.07.022_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2005.09.011","article-title":"The ubiquitous role of nitric oxide in cardioprotection","volume":"40","author":"Jones","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jss.2020.07.022_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1590\/S0100-879X1999001100004","article-title":"Vascular changes after cardiopulmonary bypass and ischemic cardiac arrest: roles of nitric oxide synthase and cyclooxygenase","volume":"32","author":"Sellke","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jss.2020.07.022_bib8","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0022-5223(05)80173-4","article-title":"Constitutive nitric oxide release is impaired after ischemia and reperfusion","volume":"110","author":"Engelman","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib9","doi-asserted-by":"crossref","first-page":"II328","DOI":"10.1161\/circ.100.suppl_2.Ii-328","article-title":"Serotonin-induced coronary contraction increases after blood cardioplegiareperfusion: role of COX-2 expression","volume":"100","author":"Metais","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2020.07.022_bib10","doi-asserted-by":"crossref","first-page":"e0124025","DOI":"10.1371\/journal.pone.0124025","article-title":"Endothelial dysfunction of bypass graft: direct comparison of in\u00a0vitro and in\u00a0vivo models of ischemia-reperfusion injury","volume":"10","author":"Veres","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2020.07.022_bib11","doi-asserted-by":"crossref","first-page":"22546","DOI":"10.1074\/jbc.M302227200","article-title":"Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase","volume":"278","author":"Kuzkaya","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2020.07.022_bib12","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1010-7940(01)01099-5","article-title":"Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update","volume":"21","author":"Paparella","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib13","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1159\/000443098","article-title":"iNOS induces vascular endothelial cell migration and apoptosis via autophagy in ischemia\/reperfusion injury","volume":"3","author":"Zhu","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jss.2020.07.022_bib14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.athoracsur.2004.10.003","article-title":"Effect of cardioplegic and organ preservation solutions and their components on coronary endothelium-derived relaxing factors","volume":"80","author":"Yang","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib15","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.bjp.0707272","article-title":"Nitric oxide homeostasis as a target for drug additives to cardioplegia","volume":"151","author":"Podesser","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib16","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1096\/fj.03-0115fje","article-title":"Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase","volume":"17","author":"Hein","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jss.2020.07.022_bib17","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s00268-010-0520-6","article-title":"New strategy of endothelial protection in cardiac surgery: use of enhancer of endothelial nitric oxide synthase","volume":"34","author":"Xue","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib18","first-page":"II407","article-title":"Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion","volume":"94","author":"Engelman","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2020.07.022_bib19","first-page":"II274","article-title":"The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia","volume":"96","author":"Amrani","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2020.07.022_bib20","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.healun.2004.11.012","article-title":"Cardiac allograft preservation using donor-shed blood supplemented with L-arginine","volume":"24","author":"Ramzy","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jss.2020.07.022_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2003.08.015","article-title":"Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts","volume":"97","author":"Kiziltepe","year":"2004","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jss.2020.07.022_bib22","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.athoracsur.2005.10.003","article-title":"Reduced cytokines release and myocardial damage in coronary artery bypass patients due to L-arginine cardioplegia supplementation","volume":"81","author":"Colagrande","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0310057X1204000110","article-title":"L-arginine cardioplegia reduces oxidative stress and preserves diastolic function in patients with low ejection fraction undergoing coronary artery surgery","volume":"40","author":"Andrews","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jss.2020.07.022_bib24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cvr\/cvp303","article-title":"Arginase inhibition mediates cardioprotection during ischaemia-reperfusion","volume":"85","author":"Jung","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2020.07.022_bib25","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1172\/JCI650","article-title":"Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats","volume":"101","author":"Cosentino","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jss.2020.07.022_bib26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0008-6363(03)00390-0","article-title":"Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model","volume":"59","author":"Malo","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2020.07.022_bib27","first-page":"95","article-title":"Cardioprotective effects of tetrahydrobiopterin in cold heart preservation after cardiac arrest","volume":"12","author":"Yamashiro","year":"2006","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejcts.2006.06.012","article-title":"Effect of tetrahydrobiopterin on selective endothelial dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary bypass","volume":"30","author":"Stevens","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib29","first-page":"695","article-title":"Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass","volume":"40","author":"Szabo","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/FJC.0b013e318123f854","article-title":"Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease","volume":"50","author":"Moens","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1258\/000456307780945741","article-title":"Nitric oxide accelerates the degradation of tetrahydrobiopterin but not total neopterin in cerebrospinal fluid; potential implications for the assessment of tetrahydrobiopterin metabolism","volume":"44","author":"Lam","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jss.2020.07.022_bib32","doi-asserted-by":"crossref","first-page":"e026664","DOI":"10.1136\/bmjopen-2018-026664","article-title":"Study protocol: NITric oxide during cardiopulmonary bypass to improve recovery in Infants with congenital heart defects (NITRIC trial): a randomized controlled trial","volume":"9","author":"Schlapbach","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jss.2020.07.022_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cardiores.2007.04.014","article-title":"Inhaled NO as a therapeutic agent","volume":"75","author":"Bloch","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2020.07.022_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4103\/0970-9185.142799","article-title":"Sodium nitroprusside in 2014: a clinical concepts review","volume":"30","author":"Hottinger","year":"2014","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/oxfordjournals.eurheartj.a061624","article-title":"Nifedipine versus nitroprusside for controlling hypertensive episodes during coronary artery bypass surgery","volume":"5","author":"Hess","year":"1984","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jss.2020.07.022_bib36","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/00003246-199212000-00006","article-title":"Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside","volume":"20","author":"Halpern","year":"1992","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jss.2020.07.022_bib37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0003-4975(99)00157-5","article-title":"Sodium nitroprusside during coronary artery bypass grafting: evidence for an antiinflammatory action","volume":"67","author":"Massoudy","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib38","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/0018578717722538","article-title":"Examining the use of sodium nitroprusside in coronary artery bypass grafting: is the benefit worth the cost?","volume":"52","author":"Gibson","year":"2017","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.jss.2020.07.022_bib39","doi-asserted-by":"crossref","first-page":"24076","DOI":"10.1074\/jbc.M116.752071","article-title":"formation of nitric oxide by aldehyde dehydrogenase-2 is necessary and sufficient for vascular bioactivation of nitroglycerin","volume":"291","author":"Opelt","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2020.07.022_bib40","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1111\/ajt.12249","article-title":"Enhanced preservation of pig cardiac allografts by combining erythropoietin with glyceryl trinitrate and zoniporide","volume":"13","author":"Watson","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jss.2020.07.022_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00003495-198427010-00003","article-title":"Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy","volume":"27","author":"Sorkin","year":"1984","journal-title":"Drugs"},{"key":"10.1016\/j.jss.2020.07.022_bib42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/0971-9784.173020","article-title":"Comparison of levosimendan and nitroglycerine in patients undergoing coronary artery bypass graft surgery","volume":"19","author":"Sahu","year":"2016","journal-title":"Ann Card Anaesthes"},{"key":"10.1016\/j.jss.2020.07.022_bib43","first-page":"5","article-title":"Use of clevidipine as an alternative to nitroglycerin in cardiac surgery: case report and current literature","volume":"7","author":"Cloud","year":"2019","journal-title":"Anaesthes J"},{"key":"10.1016\/j.jss.2020.07.022_bib44","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/jm00115a013","article-title":"Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects","volume":"34","author":"Maragos","year":"1991","journal-title":"J Med Chem"},{"key":"10.1016\/j.jss.2020.07.022_bib45","first-page":"1113","article-title":"The nitric oxide donor, diethylamine NONOate, enhances preservation of the donor rat heart","volume":"17","author":"Du","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jss.2020.07.022_bib46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjp.0707224","article-title":"Recent developments in nitric oxide donor drugs","volume":"151","author":"Miller","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/sj.bjp.0703700","article-title":"S-Nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery","volume":"131","author":"Sogo","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2020.07.022_bib49","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/S0140-6736(94)90287-9","article-title":"Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty","volume":"344","author":"Langford","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jss.2020.07.022_bib50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cardiores.2003.11.034","article-title":"Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects","volume":"61","author":"Vilahur","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2020.07.022_bib51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1476-5381.1996.tb15701.x","article-title":"The mechanism of cardioprotection by S-nitrosoglutathione monoethyl ester in rat isolated heart during cardioplegic ischaemic arrest","volume":"119","author":"Konorev","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib52","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.healun.2005.08.004","article-title":"S-nitroso human serum albumin attenuates ischemia\/reperfusion injury after prolonged cardioplegic arrest in isolated rabbit hearts","volume":"24","author":"Semsroth","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jss.2020.07.022_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/icvts\/ivu383","article-title":"The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats","volume":"20","author":"Treschera","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2009.03.005","article-title":"Dinitrosyl iron complexes with thiolate ligands: physico-chemistry, biochemistry and physiology","volume":"21","author":"Vanin","year":"2009","journal-title":"Nitric Oxide Biol Chem"},{"key":"10.1016\/j.jss.2020.07.022_bib55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00424-018-02251-2","article-title":"Protective efficacy of dinitrosyl iron complexes with reduced glutathione in cardioplegia and reperfusion","volume":"471","author":"Pisarenko","year":"2019","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jss.2020.07.022_bib56","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00005344-199509000-00009","article-title":"Development of nitrate tolerance in human arteries and veins: comparison of nitroglycerin and SPM 5185","volume":"26","author":"Arnet","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib57","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00005344-199405000-00012","article-title":"Novel organic nitrates are potent dilators of large coronary arteries with reduced development of tolerance during long-term infusion in dogs: role of the sulfhydryl moiety","volume":"23","author":"Zanzinger","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib58","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.88.5.2337","article-title":"Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs","volume":"88","author":"Lefer","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jss.2020.07.022_bib59","first-page":"H771","article-title":"Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion","volume":"263","author":"Siegfried","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jss.2020.07.022_bib60","first-page":"423","article-title":"Augmentation of microvascular nitric oxide improves myocardial performance following global ischemia","volume":"10","author":"Hammon","year":"1995","journal-title":"J Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib61","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-5223(95)70198-2","article-title":"Blood cardioplegia enhanced with nitric oxide donor spm-5185 counteracts postischemic endothelial and ventricular dysfunction","volume":"109","author":"Nakanishi","year":"1995","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-5223(94)70255-1","article-title":"Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegia hypoxia","volume":"108","author":"Sugimoto","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib63","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/0003-4975(96)00145-2","article-title":"Is potassium channel opening an effective form of preconditioning before cardioplegia?","volume":"61","author":"Menache","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1034\/j.1399-6576.2002.460105.x","article-title":"Effects of nicorandil on myocardial function and metabolism in the post-ischaemic reperfused heart with or without inhalation anaesthetics","volume":"46","author":"Furuya","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jss.2020.07.022_bib65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00003643-200701000-00005","article-title":"Myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass","volume":"24","author":"Chinnan","year":"2007","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.jss.2020.07.022_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.shk.0000168874.83401.3f","article-title":"Nicorandil attenuates NF-kB activation, adhesion molecule expression, and cytokine production in patients with coronary artery bypass surgery","volume":"24","author":"Kawamura","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.jss.2020.07.022_bib67","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1476-5381.1991.tb09852.x","article-title":"Comparison of the effects of the novel vasodilator FK409 with those of nitroglycerin in isolated coronary artery of the dog","volume":"103","author":"Yamada","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib68","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(94)90703-X","article-title":"Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409","volume":"257","author":"Kita","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0021-9150(95)05563-C","article-title":"K FK409, a new nitric oxide donor. suppresses smooth muscle proliferation in the rat model of balloon angioplasty","volume":"117","author":"Seki","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jss.2020.07.022_bib70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.RES.87.1.66","article-title":"FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model","volume":"87","author":"Fukada","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.jss.2020.07.022_bib71","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1527-3466.1996.tb00224.x","article-title":"FK409, a novel spontaneous NO releaser: comparative pharmacological studies with ISDN","volume":"14","author":"Kita","year":"1996","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.jss.2020.07.022_bib72","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00005344-200110000-00012","article-title":"Protective effects of FK409, a novel nitric oxide donor, against postischemic myocardial dysfunction in Guinea-pig hearts","volume":"38","author":"Cao","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib73","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0003-4975(00)01924-X","article-title":"Cardioprotective effects of FK409, a nitric oxide donor, after isolated rat heart preservation for 16 hours","volume":"70","author":"Zhang","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib74","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S1053-2498(00)00122-4","article-title":"FK409 ameliorates ischemia-reperfusion injury in heart transplantation following 12-hour cold preservation","volume":"19","author":"Mohara","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jss.2020.07.022_bib75","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/1568026054679308","article-title":"Hydroxyimine NO-donors; FK409 and derivatives","volume":"5","author":"Yoshida","year":"2005","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jss.2020.07.022_bib76","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pharmthera.2005.04.001","article-title":"Emerging roles of apelin in biology and medicine","volume":"107","author":"Kleinz","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jss.2020.07.022_bib77","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1111\/bph.13038","article-title":"Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia-reperfusion injury","volume":"172","author":"Pisarenko","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib78","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pharmthera.2010.09.003","article-title":"Adipocytokines, cardiovascular pathophysiology and myocardial protection","volume":"129","author":"Smith","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jss.2020.07.022_bib79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.peptides.2015.09.001","article-title":"Signaling pathways of a structural analogue of apelin-12 involved in myocardial protection against ischemia\/reperfusion injury","volume":"73","author":"Pisarenko","year":"2015","journal-title":"Peptides"},{"key":"10.1016\/j.jss.2020.07.022_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jss.2014.11.007","article-title":"Enhancement of crystalloid cardioplegic protection by structural analogs of apelin-12","volume":"194","author":"Pisarenko","year":"2015","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2020.07.022_bib81","doi-asserted-by":"crossref","first-page":"170320","DOI":"10.1016\/j.peptides.2020.170320","article-title":"[MeArg1, NLe10]-apelin-12: optimization of solid-phase synthesis and evaluation of biological properties in vitro and in vivo","volume":"129","author":"Sidorova","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.jss.2020.07.022_bib82","first-page":"942","article-title":"New nitric oxide donors with therapeutic potential","volume":"120","author":"Buca","year":"2016","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.jss.2020.07.022_bib83","doi-asserted-by":"crossref","first-page":"1701043","DOI":"10.1002\/advs.201701043","article-title":"Progress and promise of nitric oxide-releasing platforms","volume":"5","author":"Yang","year":"2018","journal-title":"Adv Sci"},{"key":"10.1016\/j.jss.2020.07.022_bib84","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10741-013-9397-4","article-title":"New perspectives of nitric oxide donors in cardiac arrest and cardiopulmonary resuscitation treatment","volume":"9","author":"Kruzliak","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jss.2020.07.022_bib85","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.lfs.2003.10.042","article-title":"iNOS-mediated nitric oxide production and its regulation","volume":"75","author":"Aktan","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.jss.2020.07.022_bib86","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0008-6363(99)00184-4","article-title":"The cardiovascular effects and implications of peroxynitrite","volume":"44","author":"Ronson","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2020.07.022_bib87","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Jagtap","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jss.2020.07.022_bib88","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.jtcvs.2012.02.008","article-title":"Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation","volume":"143","author":"Szab\u00f3","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib89","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/ars.2008.2117","article-title":"Gap junctions in the control of vascular function","volume":"11","author":"Figueroa","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jss.2020.07.022_bib90","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.bbamem.2011.07.031","article-title":"Interaction between nitric oxide signaling and gap junctions: effects on vascular function","volume":"1818","author":"Looft-Wilson","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jss.2020.07.022_bib91","first-page":"21","article-title":"Low concentrations of an nitric oxide-donor combined with a liposoluble antioxidant compound enhance protection against reperfusion injury in isolated rat hearts","volume":"61","author":"Rastaldo","year":"2010","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib92","doi-asserted-by":"crossref","first-page":"H1365","DOI":"10.1152\/ajpheart.00029.2010","article-title":"Loss of connexin40 is associated with decreased endothelium-dependent relaxations and eNOS levels in the mouse aorta","volume":"299","author":"Alonso","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jss.2020.07.022_bib93","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1161\/ATVBAHA.112.252783","article-title":"Vascular hypoxic preconditioning relies on TRPV4-dependent calciuminflux and proper intercellular gap junctions communication","volume":"32","author":"Rath","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jss.2020.07.022_bib94","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/cvr\/cvu063","article-title":"Endothelial Cx40 limits myocardial ischaemia\/reperfusion injury in mice","volume":"102","author":"Morel","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jss.2020.07.022_bib95","first-page":"765","article-title":"Cellular and molecular mechanisms of endothelial ischemia\/reperfusion\u00a0injury: perspectives and implications for postischemic myocardial protection","volume":"8","author":"Yang","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jss.2020.07.022_bib96","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jtcvs.2014.02.026","article-title":"Activation of canonical transient receptor potential channels preserves Ca2+ entry and endothelium-derived hyperpolarizing factor- mediated function in\u00a0vitro in porcine coronary endothelial cells and coronary arteries under conditions of hyperkalemia","volume":"148","author":"Yang","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib97","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1139\/y2012-075","article-title":"Endothelial calcium-activated potassium channels as therapeutic targets to enhance availability of nitricoxide","volume":"90","author":"Kerr","year":"2012","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jss.2020.07.022_bib98","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jtcvs.2010.04.005","article-title":"Use of intermediate\/small conductance calcium- activated potassium-channel activator for endothelial protection","volume":"141","author":"Yang","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2020.07.022_bib99","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/ATVBAHA.107.143578","article-title":"Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium- derived nitric oxide and endothelial progenitor cells","volume":"27","author":"Kimura","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jss.2020.07.022_bib100","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.RES.0000185811.71306.8b","article-title":"Transplantation of blood-derived progenitor cells afterrecanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study","volume":"97","author":"Erbs","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jss.2020.07.022_bib101","first-page":"395","article-title":"Potential mechanism for endothelial progenitor cell therapy in acute myocardial infarction: activation of VEGF- PI3K\/Akte-NOS pathway","volume":"43","author":"Cheng","year":"2013","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.jss.2020.07.022_bib102","doi-asserted-by":"crossref","first-page":"572729","DOI":"10.1155\/2013\/572729","article-title":"Effects of endothelial progenitor cell-derived microvesicles on hypoxia\/reoxygenation-induced endothelial dysfunction and apoptosis","volume":"2013","author":"Wang","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jss.2020.07.022_bib103","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pharmthera.2016.11.004","article-title":"Modulating MicroRNAs in cardiac surgery patients: novel therapeutic opportunities?","volume":"170","author":"Biglino","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jss.2020.07.022_bib104","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1749-6632.2002.tb04080.x","article-title":"Nitric oxide-releasing drugs. A novel class of effective and safe therapeutic agents","volume":"962","author":"Burgaud","year":"2002","journal-title":"Ann N Y Acad Sci"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480420304790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:51:26Z","timestamp":1758379886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480420304790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":104,"alternative-id":["S0022480420304790"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2020.07.022","relation":{},"ISSN":["0022-4804"],"issn-type":[{"type":"print","value":"0022-4804"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating the Bioactivity of Nitric Oxide as a Therapeutic Strategy in Cardiac Surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2020.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}